Nemiroff Alex 4

Accession 0001104659-25-115099

CIK 0001689548other

View on SEC.gov Company Profile

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 9:41 PM ET

Size

29.5 KB

Accession

0001104659-25-115099

Insider Transaction Report

Form 4

Period: 2025-11-20

Praxis Precision Medicines, Inc.PRAX

Nemiroff Alex

General Counsel and Secretary

Transactions

Exercise/Conversion
Common Stock
2025-11-20$133.65/sh+6,230$832,640→ 28,775.667 total
Sale
Common Stock
2025-11-20$192.53/sh−13,339$2,568,198→ 30,908.667 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−6,230→ 0 total
Exercise: $133.65Exp: 2030-09-13→ Common Stock (6,230 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−5,652→ 2,347 total
Exercise: $44.40Exp: 2033-01-12→ Common Stock (5,652 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−9,100→ 19,717 total
Exercise: $56.94Exp: 2034-07-29→ Common Stock (9,100 underlying)
Exercise/Conversion
Common Stock
2025-11-20$44.40/sh+2,434$108,070→ 31,209.667 total
Sale
Common Stock
2025-11-20$190.86/sh−1,714$327,139→ 44,247.667 total
Exercise/Conversion
Common Stock
2025-11-20$44.40/sh+5,652$250,949→ 36,861.667 total
Exercise/Conversion
Common Stock
2025-11-20$83.85/sh+1,714$143,719→ 22,545.667 total
Sale
Common Stock
2025-11-20$193.23/sh−977$188,789→ 29,931.667 total
Sale
Common Stock
2025-11-20$194.30/sh−9,100$1,768,130→ 20,831.667 total
Exercise/Conversion
Common Stock
2025-11-20$56.94/sh+9,100$518,154→ 45,961.667 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−1,714→ 0 total
Exercise: $83.85Exp: 2030-06-04→ Common Stock (1,714 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-20−2,434→ 0 total
Exercise: $44.40From: 2023-01-12Exp: 2033-01-12→ Common Stock (2,434 underlying)

Footnotes (7)

[F1]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $190.720 to $191.540. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
[F2]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $192.003 to $193.000. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
[F3]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $193.010 to $193.960. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
[F4]This option was fully vested as of January 1, 2024.
[F5]This option was fully vested as of September 9, 2024.
[F6]The shares underlying this stock option vested as to 25% on January 12, 2024 and the remaining shares vest in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date.
[F7]The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the Reporting Person's continued service through each vesting date.

Documents

1 file

4
tm2531977-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Praxis Precision Medicines, Inc.

CIK 0001689548

→

Entity typeother

Related Parties

filerCIK 0001827760

Filing Metadata

Form type: 4
Filed: Nov 20, 7:00 PM ET
Accepted: Nov 21, 9:41 PM ET
Size: 29.5 KB

View on SEC.gov